Does Integrated Neurocognitive Therapy (INT) reduce severe negative symptoms in schizophrenia outpatients?

Müller, Daniel; Khalesi, Zahra; Benzing, Valentin; Castiglione, Clelia I.; Roder, Volker (2017). Does Integrated Neurocognitive Therapy (INT) reduce severe negative symptoms in schizophrenia outpatients? Schizophrenia Research, 188, pp. 92-97. Elsevier 10.1016/j.schres.2017.01.037

Text Mueller.et.al_SchizophrRes.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (563kB) | Request a copy

Negative symptoms often inhibit the social integration of people suffering from schizophrenia. Reducing severe negative symptoms (SNS) in a clinically relevant way is a major unmet need. The aim of this study was to inves- tigate whether Integrated Neurocognitive Therapy (INT), a group cognitive remediation therapy (CRT), reduces SNS in schizophrenia outpatients. INT was compared with Treatment As Usual (TAU) in a randomized-controlled trial (RCT). A total of 61 SNS outpatients participated in the study, 28 were allocated to the INT group and 33 to the TAU group. A test-battery was used at baseline, post-treatment at 15 weeks, and 1-year-follow-up. Remission rates of SNS after therapy were significantly higher for INT compared to TAU. A trend favoring INT was obtained at follow-up. Furthermore, INT showed significantly higher functional outcome during follow-up compared to TAU. Regarding cognition, the strongest significant effect was found in attention post-treatment. No effects be- tween groups on more complex neurocognition and social cognition were evident. SNS outpatients seem to ac- cept INT group intervention as suggested by the high attendance rate.

Interest & Impact

Downloads

4 since deposited on 30 Jan 2018
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item